发明名称 INDOLE DERIVATIVE AND PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF
摘要 Disclosed is a compound represented by general formula (I), which has EP1 receptor antagonist activity, or a pharmacologically acceptable salt thereof. (In general formula (I), A represents a benzene ring or the like; Y represents a C1-6 alkylene group or the like; RN represents a hydrogen atom or a C1-6 alkyl group; R1 represents a hydrogen atom, a C1-6 alkyl group or the like; R2 represents an optionally substituted phenyl group, an optionally substituted five-membered aromatic heterocyclic group, an optionally substituted six-membered aromatic heterocyclic group or the like; R3 represents a halogen atom, a C1-6 alkoxy group or the like; R4 represents a hydrogen atom or the like; and R5 represents a hydrogen atom or the like.) The compound of general formula (I) is able to be used as an agent for treatment or prevention of LUTS, in particular symptoms of OABS.
申请公布号 CA2768814(A1) 申请公布日期 2011.02.03
申请号 CA20102768814 申请日期 2010.07.26
申请人 KISSEI PHARMACEUTICAL CO., LTD. 发明人 KONDO, TATSUHIRO;KONDO, ATSUSHI;TATANI, KAZUYA;KAWAMURA, NAOHIRO
分类号 C07D209/18;A61K31/404;A61K31/422;A61K31/427;A61K31/4439;A61P13/02;A61P43/00;C07D401/04;C07D401/06;C07D401/14;C07D405/04;C07D405/06;C07D405/14;C07D409/04;C07D409/06;C07D409/14;C07D413/14;C07D417/06;C07D417/14 主分类号 C07D209/18
代理机构 代理人
主权项
地址